Jaguar Health Inc Stock (JAGX) Financials Data
*All numbers in millions
| Period End Date | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|---|
| Period Length | 3 Months | 3 Months | 3 Months | 3 Months | 3 Months |
| Revenues | 93.96%1.23 | 20.27 | 3.24 | 3.08 | 2.98 |
| Cost Of Revenue | 10.97%1.03 | 1.16 | 2.20 | 0.53 | 0.53 |
15.07%3.34 | 3.93 | 14.31 | - | - | |
| Research and Development | 15.07%3.34 | 3.93 | 14.31 | - | - |
| Interest Income/Expense | 76.97%0.16 | 0.70 | 0.13 | 0.01 | -0.02 |
| Costs And Expenses | 12.57%8.82 | 10.09 | 24.48 | 10.32 | 10.99 |
| Operating Income/Loss | 174.61%-7.60 | 10.18 | -21.24 | -7.24 | -8.01 |
| Income/Loss From Equity Method Investments | 200.00%-0.03 | -0.01 | -0.04 | -0.05 | -0.04 |
| Income/Loss From Continuing Operations Before Tax | 246.76%-12.80 | 8.72 | -23.19 | -9.65 | -10.56 |
| Income Tax Expense/Benefit | - | - | - | - | - |
246.76%-12.80 | 8.72 | -23.19 | -9.65 | -10.56 | |
| Available To Common Stockholders, Basic | 81.05%-12.70 | -7.02 | -23.20 | -9.50 | -10.41 |
| Preferred Stock Dividends And Other Adjustments | 99.69%0.02 | 6.06 | - | - | - |
| Attributable To Noncontrolling Interest | 4.76%-0.12 | -0.13 | -0.13 | -0.15 | -0.15 |
| Basic Average Shares | 56.87%0.81 | 0.52 | - | 1.51 | 1.01 |
| Diluted Average Shares | 56.87%0.81 | 0.52 | - | 1.51 | 1.01 |
| Basic Earnings Per Share | 15.44%-15.70 | -13.60 | - | -6.28 | -10.26 |
| Diluted Earnings Per Share | 15.44%-15.70 | -13.60 | - | -6.28 | -10.26 |